bromodeoxyuridine has been researched along with Benign Supratentorial Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Hirano, T; Inoue, T; Ohye, C; Oriuchi, N; Shibazaki, T; Tamura, M; Tateno, M; Tomiyoshi, K; Watanabe, N | 1 |
1 other study(ies) available for bromodeoxyuridine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.
Topics: Adult; Aged; Bromodeoxyuridine; Cell Division; Child; Female; Glioma; Humans; Male; Middle Aged; Prognosis; Supratentorial Neoplasms; Survival Rate; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1993 |